Grace Wright, MD, PhD, FACR
President & CEO
Grace C Wright MD PC
New York, NY, United States
Disclosure information not submitted.
This presentation is designed to provide a clinical overview of remission data for a JAK inhibitor (JAKi) in TNF-IR adult patients with moderate to severe RA. The presentation will also provide an overview of the safety data in 18 clinical trials and across 5 indications.
Developed and offered by AbbVie